Environmental factors in HIV/AIDS epidemic development: New perspectives for gender equity and global protection against HIV transmission

Annals of the New York Academy of Sciences

Volumn 1023, Issue , 2004, Pages 164-174

  Alfsen, Annette ^a  

^a INSERM   (France)

Author keywords

AIDS epidemic; Children; HIV; Sexually transmitted infectious diseases; Socioeconomic problems; Women

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CARBOPOL 974P; CARRAGEENAN; DEXTRIN 2 SULFATE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PRO 2000; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; CULTURAL FACTOR; DEVELOPING COUNTRY; ENVIRONMENTAL FACTOR; EPIDEMIC; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PLACENTAL TRANSFER; PREVENTIVE HEALTH SERVICE; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; SOCIOECONOMICS; TOPICAL TREATMENT; VACCINATION; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 3242706676     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1319.008     Document Type: Conference Paper

References (34)

1. KAZATCHKINE, M. 2003. ANRS Research on HIV Vaccine. ANRS Publications. Paris.
2. HIV/AIDS. 2001. AIDS Epidemic Update: December 2001. Joint United Nations Program and WHO. New York.
3. UNITED NATIONS. 2000. The World's Women 2000: Trends and Statistics. Division des Statisitiques des Nations Unies. Paris.
4. OIT. 2001. ABC of Women Worker's Rights and Gender Equality. Organisation Internationale du Travail; p. 47-48. Geneva.
5. UNAIDS, 2003. Progress Report on the Global Response to HIV/AIDS Epidemic. Follow-up to the 2001 United Nations General Assembly session on HIV/AIDS. New York.
6. UNESCO, 2002. Le défi de l'equité entre les genres. Section pour les femmes et l'egalité des genres. Bureau de la planification stratégique. Paris.
7. ROCKEFELLER FOUNDATION 2002. Mobilization for Microbicides: the Decisive Decade. Rockefeller Foundation. New York.
8. MOATTI, J.P., I. N'DOYE, S.M. HAMMER et al. 2003. Antiretroviral treatment for retroviral infection in developing countries: an attainable new paradigm. Nat. Med. 9: 1449-1452.
9. BOMSEL, M. & A. ALFSEN. 2003. Entry of viruses through the epithelial barrier. Nat. Rev. Mol. Cell. Biol. 4: 57-68.
10. ALFSEN, A. & M. BOMSEL. 2002. HIV-1 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. J. Biol. Chem. 277: 25649-25659.
11. STONE, A. 2002. Microbicides: a new approach to preventing HIV and other sexually transmissible infections. Nat. Rev. Drug Discov. 1: 977-985.
12. VALDISERRI, R.O., L.L. OGDEN & E. MCCARAY. 2003. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nat. Med. 9: 881-886.
13. LETVIN, N.L., D.H. BAROUCH & D.C. MONTEFIORI. 2002. Prospects for vaccine protection against HIV-1 infection and AIDS. Annu. Rev. Immunol. 20: 73-99.
14. MCMICHAEL, A.J. & T. HANKE. 2003. HIV vaccines 1983-2003. Nat. Med. 9: 874-880.
15. KLAUSNER, R.D. 2003. The need for a global vaccine enterprise. Science 300: 2036-2039.
16. DURRANI, Z., T.L. MCINERNEY, L. MCLAIN, et al. 1998. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1 specific IgA and IgG than oral immunization. J. Immunol. Methods 220: 93-103.
17. ALFSEN, A., P. INIGUEZ, E. BOUGUYON & M. BOMSEL. 2001. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J. Immunol. 166: 6257-6265.
18. POPE, M. & A.T. HAASE. 2003. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat. Med. 9: 847-852.
19. BOMSEL, M., M. HEYMAN, H. HOCINI, et al. 1998. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dlgA or IgM. Immunity 9: 277-287.
20. MOBLEY, P.W., R. PILPA, C. BROWN, et al. 2001. Membrane perturbing domains of HIV type 1 glycoprotein41. AIDS Res. Hum. Retrov. 17: 311-327.
21. BOMSEL, M. 1997. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat. Med. 3: 42-47.
22. MENG, G., X. WEI, X. WU, et al. 2002. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5 cells. Nat. Med. 8: 150-156.
23. WYATT, R., P.D. KWONG, E. DESJARDINS, et al. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393: 705-711.
24. MASCOLA, J.R., G. STIEGLER, T.C. VANCOTT, et al. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6: 207-210.
25. BABA, T.W., V. LISKA, R. HOFMANN-LEHMANN, et al. 2000. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6: 200-206.
26. DEVITO, C., K. BROLIDEN, R. KAUL, et al. 2000. Mucosal and plasma IgA from HIV-1 exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J. Immunol. 165: 5170-5176.
27. DEVITO, C., J. HINKULA, R. KAUL, et al. 2000. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 14: 1917-1920.
28. MAZZOLI, S., L. LOPALCO, A. SALVI, et al. 1999. Human immunodeficiency virus -specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons. J. Infect. Dis. 180: 871-875.
29. KOPROWSKI, H. & V. YUSIBOV. 2001. The green revolution: plants as heterologous expression vectors. Vaccine 19: 2735-2741.
30. MASON, H.S., H. WARSECHA, T. MOR & C.J. ARNTZEN. 2002. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol. Med. 8: 324-329.
31. MOR, T.S. & H.S. MASON. 2003. Handbook of plant biotechnology. In press.
32. MARUSIC, C., P. RIZZA, L. LATTANZI, et al. 2001. Chimeric plant virus particles as immunogens for inducing murine and human immune responses against HIV-1. J. Virol. 75: 8434-8439.
33. YU, J. & W.H. LANGRIDGE. 2001. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 19: 548-552.
34. ZHANG, G.G., L. RODRIGUES, B. ROVINSKI & K.A. WHITE. 2002. Production of HIV-1 p24 protein in transgenic tobacco plants. Mol. Biotechnol. 20: 131-136.